DUBLIN, November 4, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH): 2-Day Workshop by Dr. Huber" conference to their offering.
Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated.
Method validation recently got highest attention from regulatory agencies and industry task forces. For example, FDA and EMA released guidelines on method validation and transfer, and USP has proposed new approaches chapters for integrated validation, verification and transfer of analytical procedures, for equivalency testing and for statistical evaluation.
This 2-day workshop will give attendees the background to understand the requirements, and even more significantly, it will focus on strategies and provide tools to implement most critical requirements. It will also provide templates and examples to develop inspection ready documentation. Interactive workshop exercises will be dispersed into and between the presentations. About 50% of the total time will be dedicated to practical sessions with real life examples. After the course a variety of tools such as SOPs, validation examples and checklists will be readily available on a dedicated website that can be used to easily implement what attendees have learned in the course.
Learning Objectives:
- Learn about the regulatory background and requirements for validation of analytical methods and procedures
- Learn how to plan, execute and document development and validation of methods developed in-house
- Be able to explain the different requirements for validation, verification and transfer of analytical procedures
- Understand the principles of validating methods developed in-house, verification of compendial methods, transfer of analytical procedures and demonstrating equivalency to compendial methods
- Be able to explain your company's strategy for method validation, verification, transfer and equivalency testing
- Be able to select test parameters, test conditions and acceptance criteria for different analytical tasks
- Be able to justify and document decisions about revalidation after method changes
- Be able to define and demonstrate FDA and EU compliance to auditors and inspectors
- Be able to develop inspection ready documentation during on-going routine operation
- Understand statistical evaluation of validation test results - Understanding what questions will be asked during audits and inspections and how to answer them
Handouts/ Bonus Material for Easy Implementation (available as web downloads):
- 70-page primer: Validation of analytical methods (authored by Dr. Ludwig Huber)
- 10 SOPs related to validation, verification, transfer, review and change of analytical methods
- 10 checklists, templates and examples
- Acceptance criteria for different analytical tasks
Who Should Attend:
Who will Benefit:
- QA managers and personnel
- Quality control
- Method development
- Analytical chemists
- Validation specialists
- Laboratory managers and supervisors
- Regulatory affairs
- Training departments
- Documentation departments
- Consultants
Agenda:
Day One (8:30 AM - 4:30 PM)
8:30 AM - 9:00 AM: Registration Process
9:00 AM: Session Start
Lectures and Workshop Exercises
Lecture 1 - Regulatory Background and Requirements
- FDA and international requirements
- The importance of ICH Q2 and USP chapters
- New USP Chapter 220, 1200, 1210, 1220
- Different requirements for GLP, GCP and GMP
- Impact of pharmaceutical quality systems
- The importance of risk assessment
- Lessons from recent FDA Warning Letters
- Planning for cost-effective implementation
Lecture 2
- Preparing Your Lab for Validation Studies
-Analytical instrument qualification
- Part 11 and Annex 11 compliance of computer systems and software
- Validation of chromatographic data systems
-Validation and control of Excel spreadsheets
- Training of analysts
- Documenting evidence of training efficiency
- Qualification of reference standards and materials
Lecture 3
- Validation of Analytical Methods and Procedures
- Developing a validation plan and SOP
- ICH Q2 validation and test parameters:
- Accuracy, precision, intermediate precision, specificity, LOD, LOQ, linearity, range, robustness, ruggedness
- Setting application specific acceptance criteria
- Efficient design and execution of test experiments
- Evaluation of test results: using statistical models
- Handling deviations from expected test results
Lecture 4 - Verification of Compendial Methods
- FDA and equivalent international expectations
- Scope and objectives of USP
- USP verification requirements
- Risk based approach for type and extent of testing
- Which validation parameters should be verified
- Logical process to set acceptance criteria
Day Two (8:30 AM - 4.30 PM)
Lectures and Workshop Exercises
Lecture 5 - Transfer of Analytical Methods and Procedures
-The main objective of formal method transfer
- Learnings from EU GMP Chapter 6 on method transfer
- USP: Choosing the approach for transfer
- Approach and benefits of comparative testing
- Developing a risk based test plan
- Preparing the receiving lab for the transfer
- Method transfer to new technology: HPLC to UHPLC
- Preparing the method transfer report
Lecture 6
- Demonstrating Equivalency to Compendial Methods
- Definition, objective and scope alternative methods
- Justification for the use of alternative methods
- FDA and USP requirements
- Options for alternatives to official procedures
- Equivalency testing: what and how much
- Documentation requirements
Lecture 7 - Maintaining the Validated State
- Monitoring method performance: system suitability testing and quality control samples
- Change control procedure for analytical methods
- Handling method changes vs. adjustments
- Revalidation of analytical methods: when, what to test
- Method reviews as a cost effective alternative to time based revalidation
- Regulatory reporting of post-approval changes
- Continuous improvement
Lecture 8
- Special Applications and Validation Processes
- Validation for INDA, ANDA and NDA submissions
- Validation of bioanalytical methods according to the FDA and EMA guidelines
- Validation of stability indication methods
- The integrated method lifecycle management: activities during development, validation and routine use
- Method development and validation using QbD
Speakers:
Ludwig Huber Director and Chief Editor LabCompliance
Dr. Ludwig Huber is Director and Chief Editor of www.labcompliance.com, the global on-line resource for validation and compliance issues for laboratories . Mr. Huber is an expert for FDA and equivalent international compliance and for ISO/IEC 17025 laboratory accreditation. He is also the Chairman, presenter and panel discussion member at US-FDA industry training sessions and conferences.
He served as a team member of PDA's task forces "21 CFR Part 11", of US-FDA internal documents, and of the GAMP® special interest group on laboratory equipment. In addition, he was awarded as Presenter of the Year of the Institute for Validation and Technology. He is the author of the books Validation and Qualification in Analytical Laboratories, and "Validation of Computerized Analytical and Networked Systems", Interpharm Press.
For more information about this conference visit http://www.researchandmarkets.com/research/cc6blp/validation
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
